How learnings from COVID-19 can be applied to understanding the most destructive pandemic in human history: heart disease.
Author Archives: Amanda Sheldon
Large-scale research and genetic studies concur that familial hypercholesterolemia (FH) is a common genetic condition that impacts all races and ethnicities. In fact, it is estimated that 1 in 250 individuals worldwide have FH. That means, each of us reading this FH Foundation blog probably knows … Read More
Katherine Wilemon, founder and CEO of the FH Foundation, recently authored a paper with researchers from Stanford University that highlighted key differences in care for women with familial hypercholesterolemia (FH). The paper published in Current Atherosclerosis Reports highlights the unique needs … Read More
The FH Foundation is proud to announce our partnership with the CDC Foundation as an inaugural community partner in the “Alliance for Million Hearts Campaign.” The campaign is a new public-private coalition with the nation’s leading organizations and thought leaders to confront the nation’s … Read More
It is with deep sadness that we share that Dr. William Neal, former Chairman of the Board of the FH Foundation and Professor Emeritus of Pediatrics at West Virginia University, passed away on January 1, 2021.
The FH Foundation Team and Board of Directors are extremely grateful for the contributions … Read More
You’re invited to join the FH Foundation for our annual FH Community Forum “Inherited High Cholesterol: Journeys to FH Diagnosis and Care.” This year’s event will be held virtually on Saturday, December 12 at 12:00 pm ET.
The FH Community Forum is open to individuals with familial hypercholesterolemia … Read More
We are excited to announce new data from the FH Foundation’s CASCADE FH® Registry was published in the The Journal of Pediatrics. This research helps us understand the progress that has been made in the treatment and care of children with familial hypercholesterolemia (FH) in specialty … Read More
Increasing screening for familial hypercholesterolemia is critical for finding the 85% of individuals who are not diagnosed today. The FH Foundation leads critical research to uncover some of the barriers for cascade screening, also known as family screening, and genetic testing in the United States.
Recently, … Read More
We are pleased to announce that Dr. Mary McGowan has joined the FH Foundation Team as Chief Medical Officer, effective January 2, 2020. This is Dr. McGowan’s second role with the organization. She was a founding FH Foundation board member and our first Chief Medical Officer in 2011 back when every … Read More
We are pleased to announce that Stacey Lane, JD, is the newly elected Chairwoman of the Board of the FH Foundation. Ms. Lane has contributed greatly to the growth of the FH Foundation, serving as a board member for the past six years and Vice Chair for the last four years. A graduate of the University … Read More